JOHN FREDERICK DE GROOT to Vascular Endothelial Growth Factor Receptor-2
This is a "connection" page, showing publications JOHN FREDERICK DE GROOT has written about Vascular Endothelial Growth Factor Receptor-2.
Connection Strength
0.302
-
Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models. Neuro Oncol. 2016 09; 18(9):1230-41.
Score: 0.119
-
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma. Invest New Drugs. 2015 Feb; 33(1):247-53.
Score: 0.108
-
Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy. Clin Cancer Res. 2009 Jul 15; 15(14):4589-99.
Score: 0.075